Kian Tadjalli Mehr, Johannes Fischer, Felix Spreter, Simon Reiss, David Boll, Ali Caglar Özen, Deepa Gunashekar, Constantin von Zur Mühlen, Alexander Maier, Michael Bock
{"title":"Radial Hadamard-encoded <sup>19</sup>F-MRI.","authors":"Kian Tadjalli Mehr, Johannes Fischer, Felix Spreter, Simon Reiss, David Boll, Ali Caglar Özen, Deepa Gunashekar, Constantin von Zur Mühlen, Alexander Maier, Michael Bock","doi":"10.1007/s10334-025-01254-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Developing a <sup>19</sup>F imaging method to acquire images of the molecular inflammation tracer perfluorooctyl bromide (PFOB) without chemical shift artifacts.</p><p><strong>Materials and methods: </strong>PFOB is a molecular tracer that can be used to track the response of myeloid cells. However, imaging of PFOB with <sup>19</sup>F-MRI is challenging due to its complex spectrum which leads to unwanted chemical shift artifacts. Spectral HE allows for separate reconstructions of each peak of the PFOB spectrum, which was combined into a single image after resonance shift correction. In this work, a Hadamard-encoded (HE) radial 3D UTE sequence was tested in phantoms and in vivo in a pig, measuring the <sup>19</sup>F signal in the spleen at different times after injection.</p><p><strong>Results: </strong>Chemical shift artifacts were effectively suppressed with HE, and an SNR > 100 was observed for the <sup>19</sup>F signal in the spleen 2 days after injection. The signal decreased over time, and 7 days after injection it was reduced by 30%.</p><p><strong>Discussion: </strong>Chemical shift artifact correction using HE allowed for in vivo <sup>19</sup>F PFOB imaging of labeled monocytes with a high SNR. Compared to spectrally selective excitation, HE increased the PFOB <sup>19</sup>F-MRI signal by 10%, and the simple HE-algorithm could be directly integrated into the image reconstruction of the MRI system.</p>","PeriodicalId":18067,"journal":{"name":"Magnetic Resonance Materials in Physics, Biology and Medicine","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magnetic Resonance Materials in Physics, Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10334-025-01254-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Developing a 19F imaging method to acquire images of the molecular inflammation tracer perfluorooctyl bromide (PFOB) without chemical shift artifacts.
Materials and methods: PFOB is a molecular tracer that can be used to track the response of myeloid cells. However, imaging of PFOB with 19F-MRI is challenging due to its complex spectrum which leads to unwanted chemical shift artifacts. Spectral HE allows for separate reconstructions of each peak of the PFOB spectrum, which was combined into a single image after resonance shift correction. In this work, a Hadamard-encoded (HE) radial 3D UTE sequence was tested in phantoms and in vivo in a pig, measuring the 19F signal in the spleen at different times after injection.
Results: Chemical shift artifacts were effectively suppressed with HE, and an SNR > 100 was observed for the 19F signal in the spleen 2 days after injection. The signal decreased over time, and 7 days after injection it was reduced by 30%.
Discussion: Chemical shift artifact correction using HE allowed for in vivo 19F PFOB imaging of labeled monocytes with a high SNR. Compared to spectrally selective excitation, HE increased the PFOB 19F-MRI signal by 10%, and the simple HE-algorithm could be directly integrated into the image reconstruction of the MRI system.
期刊介绍:
MAGMA is a multidisciplinary international journal devoted to the publication of articles on all aspects of magnetic resonance techniques and their applications in medicine and biology. MAGMA currently publishes research papers, reviews, letters to the editor, and commentaries, six times a year. The subject areas covered by MAGMA include:
advances in materials, hardware and software in magnetic resonance technology,
new developments and results in research and practical applications of magnetic resonance imaging and spectroscopy related to biology and medicine,
study of animal models and intact cells using magnetic resonance,
reports of clinical trials on humans and clinical validation of magnetic resonance protocols.